Company intelligence / Profile preview

CureRays

Grass Valley, California, United States

Ownership: Private
Employees: ~8
Development stage: Other

Overview

CureRays provides commercial image-guided superficial radiation therapy (IG-SRT) for skin cancer and inflammatory diseases, with >1,500 patients treated, ongoing clinical trials, and collaborative research exploring expansion to new indications such as arthritis and infectious pulmonary disease. Phase III data from trial collaboration for whole-lung low-dose radiation in COVID-19 pneumonia showed promising results.

Therapeutic areas: EndocrinologyRheumatologyInfectious DiseasesRare DiseasesMen's HealthDermatologyOncology
Modalities: Image-guided superficial radiation therapySuperficial radiotherapyLow-dose radiotherapy
Industry: Therapeutic Medical Devices

Partnerships

Sensus Healthcare

Beyond the preview

Go deeper on CureRays.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CureRays.

Explore the full profile